➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: August 8, 2020

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Duramorph Pf patents expire, and when can generic versions of Duramorph Pf launch?

Duramorph Pf is a drug marketed by Hikma and is included in one NDA.

The generic ingredient in DURAMORPH PF is morphine sulfate. There are twenty-three drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

US ANDA Litigation and Generic Entry Outlook for Duramorph Pf

A generic version of DURAMORPH PF was approved as morphine sulfate by HOSPIRA on May 11th, 1988.

  Start Trial

Drug patent expirations by year for DURAMORPH PF
Recent Clinical Trials for DURAMORPH PF

Identify potential brand extensions & 505(b)(2) entrants

Wright State UniversityPhase 4
Augusta UniversityEarly Phase 1
Maimonides Medical CenterPhase 4

See all DURAMORPH PF clinical trials

Pharmacology for DURAMORPH PF
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

US Patents and Regulatory Information for DURAMORPH PF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma DURAMORPH PF morphine sulfate INJECTABLE;INJECTION 018565-001 Sep 18, 1984 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Hikma DURAMORPH PF morphine sulfate INJECTABLE;INJECTION 018565-002 Sep 18, 1984 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.